ExploreWatchlistsPricing
  1. JP-listed companies
  2. DAIICHI SANKYO COMPANY, LIMITED
  3. Financials
  4. Pretax margin (%)

DAIICHI SANKYO COMPANY, LIMITED (4568)

Market cap
¥5.12T
P/E ratio
18.8x
Daiichi Sankyo is a global pharmaceutical company that researches, develops and sells prescription drugs and over-the-counter medicines worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 202624.5+29.69%
Mar 31, 202518.9+27.29%
Mar 31, 202414.8+49.28%
Mar 31, 20239.9+41.03%
Mar 31, 20227-8.64%
Mar 31, 20217.7-46.44%
Mar 31, 202014.4+55.74%
Mar 31, 20199.2+9.41%
Mar 31, 20188.4-8.20%
Mar 31, 20179.2-25.92%
Mar 31, 201612.4+42.70%
Mar 31, 20158.7-13.88%
Mar 31, 201410.1+1.61%
Mar 31, 20139.9+22.37%
Mar 31, 20128.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat